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Blood pressure (BP) rises in response to physical exercise 
and it is known that the magnitude of this response is 
dependent on select aspects of the exercise (e.g. type (aer-
obic or resistance exercises; static or dynamic), duration, 
intensity).1 However, factors not related to these exercise 
aspects, such as genetic factors, may also be associated 
with the BP response to exercise.2,3 Genetic factors are 
estimated to account for ~30% of the variance in resting 
BP of an adult population4 and may account to some extent 
for the variability in BP response to exercise in a load-
dependent way.2
The study of “candidate genes” to certain phenotypic 
responses, such as the hemodynamics response to exer-
cise, is one of the strategies used to verify possible associa-
tions among genetic factors and physiological response to 
exercise.5 Among many candidate genes that may be asso-
ciated with the BP response to exercise, the genes from 
elements in the renin-angiotensin system (RAS) have 
attracted considerable attention.
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Abstract
Hypothesis/introduction: The association of ACE I/D polymorphism and hemodynamic response to exercise have 
been limited to primarily aerobic exercises. We hypothesized that D allele carriers would show greater hemodynamic 
response to resistance exercise, as has been observed with aerobic. This study aimed to investigate the association 
of ACE I/D polymorphism and hemodynamic (blood pressure (BP), heart rate (HR) and rate-pressure product (RPP)) 
response to resistance exercise in young healthy subjects.
Materials and methods: ACE I/D polymorphisms were studied by PCR analysis from 75 healthy men. Subjects 
completed a resistance exercise session of three sets of 10 knee extension repetitions with loads of 50, 75 and 100% 
of 10RM and two-minute rest intervals. Hemodynamic measures were recorded before and immediately after each set. 
Analysis of variance was used to identify significant differences among ACE genotypes.
Results: ACE I/D polymorphism is associated with hemodynamic response to resistance exercise, as healthy subjects 
with ACE D allele were prone to higher responses. In addition, this phenotypic difference seems to be a load-dependent 
trend.
Conclusion: ACE DD carriers exhibit greater heart work during resistance exercise. Future studies should focus on 
the influence of resistance training period with different workloads on the hemodynamic response in healthy individuals 
with different ACE genotypes.
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Among the elements of the RAS, the angiotensin-
converting enzyme (ACE) plays a key role in regulating 
BP owing to the influence on vascular tone through the 
activation of the vasoconstrictor angiotensin II6 and inacti-
vation of the vasodilatory peptide bradykinin.7 Inter-
individual differences in blood ACE levels are, at least, in 
part explained by the presence of an insertion/deletion 
(I/D) polymorphism in intron 16 of the ACE gene,3,8 with 
greater ACE levels observed in D allele carriers. 
Notwithstanding, it has been postulated that the D allele 
carriers have a higher level of angiotensin I conversion to 
angiotensin II than I allele carriers.9
The relationship between candidate genes (i.e. ACE 
gene) and hemodynamics response to exercise have been 
proposed by many researchers.3,10–12 Previous findings 
indicated that D allele carriers have a greater hemody-
namic response to exercise when compared to I allele car-
riers, but these studies have been restricted to aerobic 
exercises.11,12 Thus, it is unclear if these findings are appli-
cable to resistance exercise, since the BP response to exer-
cise is influenced by specific components, such as type, 
intensity, or mode.
Furthermore, the inclusion of resistance exercises in 
physical activity and rehabilitation routines has been 
strongly recommended by the American College of Sports 
Medicine13,14 and American Heart Association15 owing to 
its beneficial effects for skeletal muscle and cardiovascular 
systems.
In light of the fact resistance exercise has not been stud-
ied concerning this issue and the importance of resistance 
exercise as a component of being physically active, the 
current study was undertaken. The purpose of this study 
was to investigate the association of ACE I/D gene poly-
morphism and BP response to resistance exercise in young 
healthy subjects. We hypothesized that D allele carriers 
would show greater BP response to resistance exercise, 
similar to what has been seen with aerobic exercises.
Methods
Subjects
Seventy-five healthy men, originally from the state of 
Bahia in the northeast part of Brazil (eight white Brazilians 
(ACE genotypes: one DD, six ID and one II), 37 pardo 
Brazilians(ACE genotypes: 15 DD, 15 ID and seven II) 
and 30 black Brazilians (ACE genotypes: 16 DD, eight ID 
and six II), volunteered to participate in the current study. 
All subjects underwent a clinical examination before being 
admitted into the Brazilian military service and were con-
sidered healthy (i.e. no muscle, joint or cardiovascular dis-
ease). Subjects were starting military service and had no 
recent history of an exercise training routine. The purpose 
and procedures of the experiment were explained and con-
sent was obtained prior to the commencement of the 
experiment. All procedures were approved by the local 
ethics committee according to the Declaration of Helsinki.
Genotype analysis
Blood samples were collected from an antecubital vein in a 
seated position for detection of the ACE I/D polymorphism 
using the polymerase chain reaction (PCR) amplification of 
the region of intron 16 of the gene for ACE to determine if 
the Alu repeat sequences were present. In addition, individ-
ual DNA sequences were amplified using primers flanking 
the polymorphic region (sense 5’CTG-GAG-ACC-ACT-
CCC-ATC-CTT-TCT3’ and antisense 5’GAT-GTG-GCC-
ATC-ACA-TTC-GTC-AGA-T3’). PCR profiling and 
genotyping of the I/D polymorphisms were conducted as 
described previously.8 To avoid mistyping I/D heterozy-
gotes as DD homozygotes because of the preferential ampli-
fication of the D allele in heterozygous samples, all DD 
homozygous samples were subjected to independent PCR 
amplification using a primer set that identifies an insertion-
specific sequence that has been previously reported (sense 
5’TGG-GACCAC-AGC-GCC-CGC-CAC-TAC3’ and anti-
sense 5’TCG-CCA-GCCCTC-CCA-TGC-CCA-TAA3’).8 
The reproducibility was greater than 99%, with most 
instances of error being due either to transcription or data 
entry. When discrepancies were found, the genotyping of 
the sample was repeated.
All genotyping was performed by the same researcher 
who was blinded to subject data. The study design was a 
double-blind approach with respect to the participants’ 
genotype.
Body composition measures
Body weight was assessed using a digital scale to the near-
est 0.1 kg, and height was recorded with a stadiometer to 
the nearest 0.1 cm. Measurements were made with the sub-
jects in light clothes and shoes removed. Body mass index 
(BMI) was calculated as body mass (in kilograms) divided 
by the square of height (in meters). Percentage of body fat 
and lean body mass was approximated using a three-site 
skin-fold method as proposed by the American College of 
Sports Medicine.16 A well-trained technician measured 
skin-folds three times at each site and the mean of the val-
ues was used.
Ten repetition maximum (10RM) tests and 
exercise protocol
In the week before the experiment, the load for 10RM was 
determined for each subject in a knee extension machine by 
using the maximum weight that could be lifted for 10 con-
secutive repetitions. If the subject did not accomplish 
10RM in the first attempt, the weight was adjusted by 4–10 
kg and a minimum of five minutes of rest was given before 
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the next attempt. Only three trials were allowed per testing 
session. To increase the reliability of 10RM testing, the fol-
lowing strategies were employed: (a) the 10RM was meas-
ured on two nonconsecutive days that were separated by 72 
hours, (b) exercise technique was monitored and corrected 
as needed and (c) all subjects received verbal encourage-
ment. The reliability of the 10RM loads was assessed with 
the intraclass correlation coefficient (ICC) and showed 
high reliability (ICC, r = 0.95). A week after the last 10RM 
test, subjects performed three sets of 10 repetitions of knee 
extension at 50% (first set), 75% (second set) and 100% 
(third set) of 10 RM, with two-minute rest intervals between 
sets. Subjects were instructed on proper breathing tech-
nique to avoid the occurrence of a Valsalva maneuver. To 
ensure that all subjects were moving at approximately the 
same velocity for each repetition, each set was timed using 
a metronome, which called out a cadence for the eccentric 
and concentric phases of each repetition. The repetition 
cadence consisted of a two-second eccentric phase fol-
lowed by a two-second concentric phase.
Hemodynamics measures
Using standardized techniques,17 a well-trained technician 
measured systolic and diastolic blood pressure by auscul-
tation using a calibrated aneroid sphygmomanometer 
(BD®, Germany) and a stethoscope (BD®, Germany). 
Systolic blood pressure (SBP) was recorded as the moment 
of hearing the first Korotkoff sound and diastolic blood 
pressure (DBP) as the moment of disappearance of the last 
Korotkoff sound. SBP and DBP were measured once 
before (i.e. at rest) and immediately after the end of each 
set of the exercise. BP values were also measured immedi-
ately after each exercise set, because our aim was to study 
the acute response to resistance. BP increases immediately 
after resistance exercise execution, and then lowers to the 
pre-exercise values in just a few seconds (i.e. BPs can 
reduce very quickly following resistance exercise). Thus, 
to measure the acute hemodynamic response, BP was 
measured only immediately after each resistance exercise 
execution.
The mean blood pressure (MBP) was calculated using 
the formula: MBP = DBP + (SBP–DBP/3), for each BP 
measure (i.e. before and after each exercise set). To avoid 
the intersubject variability, the same well-trained techni-
cian performed all BP measures.
Intra-arterial pressure measurement is considered the 
gold-standard method for assessing BP, and the auscultation 
method tends to underestimate this parameter. However, the 
intra-arterial measurement is an invasive procedure that 
might put participants at excessive risk, which leads to a 
recommendation to avoid its use in healthy subjects.18,19
Heart rate (HR) was monitored with a heart rate moni-
tor (HRM) (Polar, Kempele, Finland) and recorded before 
(i.e. at rest) and immediately after the end of each set of the 
exercise, simultaneously to BP measures. The rate-pres-
sure product (RPP) was calculated as the product of HR 
(beats per minutes) and systolic arterial pressure (mmHg) 
multiplied by 10−3, following recommendations.20–22
RPP was included to evaluate the association between 
the ACE I/D gene polymorphism and heart work during 
the resistance exercise protocol. RPP is directly propor-
tional to the work performed by the heart and considered 
to be a useful index of myocardial oxygen consumption 
during exercise,23–25 which is the most important indicator 
of the load on the heart.22 Myocardial oxygen consumption 
is difficult to measure directly, which makes RPP a non-
cumbersome measure of myocardial oxygen consumption 
during ambulatory conditions
Statistical analysis
After genotype analyses, subjects were placed into three 
groups according to allele frequency: II, ID or DD. A χ2 
test was used to determine whether the observed genotype 
frequency was in Hardy-Weinberg equilibrium (expected 
frequency of alleles: (p²+2pq+q²=1), where p is the more 
common allele and q is the less common allele).26 The reli-
ability of the 10RM load assessments was determined with 
the ICC and the reliability was categorized as “excellent” 
for ICC values in the range of 0.8–1.0 and “good” for 0.6–
0.8, whereas values <0.6 were “poor.”27
A one-way analysis of variance (ANOVA) was used to 
test the differences in age, body composition, exercise load 
(10RM) and hemodynamic variables before the first exer-
cise set among the ACE I/D gene polymorphisms (i.e. II, 
ID and DD). A three-way ANOVA (three genotypes × two 
time (PRE- and POST-exercise) × 3 sets) was used to com-
pare SBP, DBP, MBP, HR and RPP during exercise. 
Significant main effects were analyzed using pairwise 
comparisons and followed by Tukey post hoc tests. 
Statistical significance for all analyses was accepted at p ≤ 
0.05. Statistical analysis was completed using PASW 18 
statistical package (SPSS Inc, Chicago, IL, USA.).
Results
A χ2 analysis indicated that the genotype frequencies of the 
subjects were in Hardy-Weinberg equilibrium (p = 0.61). 
Table 1 shows the body composition, exercise load (10RM) 
and resting blood pressure of the subjects after separation 
according to ACE genotype group. There were no signifi-
cant differences between groups in age and any of the body 
composition measures (height, body weight, BMI, per-
centage of body fat and lean body mass) (p > 0.05). None 
of the subjects enrolled in the study displayed hyperten-
sion (i.e., blood pressure ≥140/90 mmHg);16 although sub-
jects with ACE DD genotype had clinically similar but 
significantly higher resting SBP when compared to II and 
ID genotypes (p < 0.05; see Table 1).
1254 Journal of the Renin-Angiotensin-Aldosterone System 16(4) 
SBP showed a significant main effect for time 
(F1,432 = 738.38; p < 0.001; observed power = 1.00), sets 
(F2,432 = 55.70; p < 0.001; observed power = 1.00) and 
genotypes (F2,432 = 15.70; p < 0.001; observed power = 
0.99) (Figure 1). The post hoc analysis indicated that 
subjects carrying DD alleles had greater SBP responses 
with each exercise set when compared to other geno-
types (i.e. II or ID) (p < 0.05). Additionally, we observed 
a progressive increase in SBP with the sets (p < 0.05); 
that is, with the increasing exercise load.
DBP showed a significant main effect for time (F1,432 = 
58.83; p < 0.001; observed power = 1.00), sets (F2,432 = 3.20; 
p < 0.05; observed power = 0.61) and genotypes (F2,432 = 
13.75; p < 0.001; observed power = 0.99) (Figure 2). The 
post hoc analysis indicated that subjects carrying DD alleles 
have greater DBP response with each exercise set when 
compared to other genotypes (i.e. II or ID) (p < 0.05). 
Between the sets, significant differences existed only 
between the first and third sets (p < 0.05).
MBP also showed a significant main effect for time 
(F1,432 = 485.75; p < 0.001; observed power = 1.00), sets 
(F2,432 = 33.17; p < 0.001; observed power = 1.00) and 
genotypes (F2,432 = 21.91; p < 0.001; observed power = 
1.00) (Figure 3). The post hoc analysis indicated that sub-
jects carrying DD alleles have greater MBP response with 
each exercise set when compared to other genotypes (i.e. II 
or ID) (p < 0.05). Genotype differences in MBP were 
observed both before and immediately after exercise, with 
Table 1. Mean±SE of body composition, exercise load (10 RM) and rest blood pressure of volunteers by ACE genotypes (II, ID and 
DD).
II (n = 14) ID (n = 29) DD (n = 32) p
Age (year) 19±0.2 19±0.1 19±0.1 0.252
Height (cm) 175±1 178±1 177±1 0.604
Body weight (kg) 66±2 71±2 71±2 0.483
BMI (kg/m2) 22±1 22±1 23±1 0.613
Percentage body fat (%) 14±1 14±1 14±1 0.966
Lean body mass (kg) 57±2 61±1 61±1 0.319
10 RM (kg) 31±1 32±1 33±1 0.349
Systolic blood pressure (mmHg) 120±1 120±1 124±1a 0.002
Diastolic blood pressure (mmHg) 80±1 81±1 82±1 0.123
Mean blood pressure (mmHg) 93±1 94±1 96±1a 0.010
Heart rate (bpm) 79±3 79±3 81±2 0.751
Rate-pressure product (mmHg.bpm.10−3) 9.4±0.4 9.5±0.4 10.1±0.3 0.361
ACE: angiotensin-converting enzyme; BMI: body mass index; RM: repetition maximum; bpm: beats per minute. aSignificant difference among genotype 
DD and other genotypes (p < 0.05).
Figure 1. Mean±SE of SBP, before and after each exercise set, from ACE gene genotypes II, ID and DD. Note that the scale starts 
at 100 mmHg. *Significant difference between PRE- and POST-exercise measures (p < 0.05); #Significantly different from other 
exercise sets (p < 0.05); §significant difference among genotype DD and all other genotypes (p < 0.05). ACE: angiotensin-converting 
enzyme; I: insertion; D: deletion; SBP: systolic blood pressure.
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particularly marked differences after the last sets (p < 
0.05). Additionally, we observed a progressive increase in 
MBP with the sets (p < 0.05); that is, with the increasing 
exercise load.
HR showed a significant main effect for time (F1,432 = 
448.96; p < 0.001; observed power = 1.00), sets (F2,432 = 
23.680; p < 0.001; observed power = 0.61) and genotypes 
(F2,432 = 4.49; p = 0.01; observed power = 0.77) (Figure 4). 
Post hoc analysis indicated that subjects carrying DD 
alleles have greater HR response with each exercise set 
when compared to ID carriers (p < 0.05), while the differ-
ence between DD and II carriers was borderline significant 
(p = 0.06). Between the sets, significant differences were 
observed only between first and third sets (p < 0.05).
RPP also showed a significant main effect for time 
(F1,432 = 706.97; p < 0.001; observed power = 1.00), sets 
(F2,432 = 49.13; p < 0.001; observed power = 1.00) and 
genotypes (F2,432 = 9.46; p < 0.001; observed power = 
0.98) (Figure 5). The post hoc analysis indicated that sub-
jects carrying DD alleles have greater RPP response with 
Figure 2. Mean±SE of DBP, before and after each exercise set, from ACE gene genotypes II, ID and DD. Note that the scale starts 
at 50 mmHg. *Significant difference between PRE- and POST-exercise measures (p < 0.05); ¥significantly different from first exercise 
set (p < 0.05); §significant difference among genotype DD and all other genotypes (p < 0.05).
ACE: angiotensin-converting enzyme; I: insertion; D: deletion; DBP: diastolic blood pressure.
Figure 3. Mean±SE of MBP, before and after each exercise set, from ACE gene genotypes II, ID and DD. Note that the scale 
starts at 60 mmHg. *Significant difference between PRE- and POST-exercise measures (p < 0.05); #significantly different from other 
exercise sets (p < 0.05); §significant difference among genotype DD and all other genotypes (p < 0.05).
ACE: angiotensin-converting enzyme; I: insertion; D: deletion; DBP: mean blood pressure.
1256 Journal of the Renin-Angiotensin-Aldosterone System 16(4) 
each exercise set when compared to other genotypes (i.e. II 
or ID) (p < 0.05). Additionally, a progressive increase in 
RPP was observed with the sets (p < 0.05); that is, with the 
increasing exercise load.
Discussion
Our main study finding was that healthy subjects with the 
ACE D allele had higher hemodynamic responses to 
resistance exercise. In addition, young healthy DD carri-
ers showed a significantly greater resting SBP and MBP 
before the exercise.
Previous studies reported that the magnitude of 
increase in BP during exercise is an independent pre-
dictor of left ventricular (LV) hypertrophy, and the risk 
of stroke and death.28,29 Interestingly, the ACE D allele 
has been associated with exercise-induced LV hyper-
trophy30–33 after exercise training (military training 
involving resistance and endurance exercises); specifi-
cally, training-induced LV mass increases could be 2.7 
times greater in the DD homozygotes than in the II 
homozygotes.31
The genotypic difference in the hemodynamic and LV 
mass responses to exercise may be related to the greater 
Figure 4. Mean±SE of HR, before and after each exercise set, from ACE gene genotypes II, ID and DD. Note that the scale starts 
at 40 bpm. *Significant difference between PRE- and POST-exercise measures (p < 0.05); #significantly different from other exercise 
sets (p < 0.05); ‡significant difference between the DD and ID genotypes (p < 0.05).
ACE: angiotensin-converting enzyme; I: insertion; D: deletion; HR: heart rate.
Figure 5. Mean±SE of RPP, before and after each exercise set, from ACE gene genotypes II, ID and DD. Note that the scale starts 
at 4 mmHg/beats.10−3. *Significant difference between PRE- and POST-exercise measures (p < 0.05); #significantly different from 
other exercise sets (p < 0.05); §significant difference among genotype DD and all other genotypes (p < 0.05).
ACE: angiotensin-converting enzyme; I: insertion; D: deletion; RPP: rate-pressure product.
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ACE levels observed in D allele carriers, compared to I 
allele carriers. The greater ACE levels observed in D allele 
carriers may lead to higher levels of angiotensin I conver-
sion to angiotensin II than I allele carriers.9 The suscepti-
bility for LV hypertrophy from ACE D allele carriers may 
therefore result from direct action of angiotensin II over 
the ventricular muscle,34 and/or an indirect way, through 
vasoconstrictor action over arterioles,6 generating addi-
tional blood flow resistance and potentially a myocardial 
overload.
Angiotensin II is a known vasoconstrictor mediator act-
ing on type 1 (AT1) receptors, increasing the resistance to 
blood flow,6 which leads to LV hypertrophy35 owing to an 
increased pressure load (“after load”). In addition, circu-
lating angiotensin II has peripheral and central effects on 
the autonomic nervous system (ANS), increasing sympa-
thetic outflow.6,36,37 This can lead to additional blood flow 
resistance and the potential for myocardial overload dur-
ing exercise.
DD carriers had a greater HR during the resistance 
exercise protocol, which suggests a higher sympathetic 
outflow. Yet, the relationship between the ANS and angi-
otensin II could be more complex, since the activation of 
β1-receptors in juxtaglomerular (JG) cells increases 
renin secretion, the rate-limiting enzyme in the forma-
tion of angiotensin II.38 Despite our hypothesis about the 
interplay between the ACE gene polymorphism and 
ANS, further studies are required to investigate this 
issue, since HR is influenced by the ANS among other 
factors, and the sympathetic outflow was not measured 
directly.
The BP and RPP response to resistance exercise was 
associated with the ACE I/D polymorphism, with the 
greatest responses occurring in the D allele carriers, espe-
cially DD homozygous, which partially explains the previ-
ous findings about the association between exercise-induced 
LV hypertrophy and ACE I/D polymorphism.30–33 The 
greater RPP of DD carriers during exercise reinforces this 
hypothesis since this hemodynamic parameter is a useful 
index of heart work and myocardial oxygen consumption 
during exercise.23,24
The greater ACE activity at rest of D allele carriers, as 
reported by a previous study,9 may also have existed in our 
subjects and thus explains our observed greater SBP and 
MBP before the exercise protocol (i.e. at rest) when com-
pared to I allele carriers. Although our sample was healthy 
young subjects (~19 years) without signs of cardiovascular 
disease after a clinical examination, and with no recent 
history of an exercise training routine, heart structural 
remodeling could already be present and influence the 
hemodynamics. Yet, our study investigated only the hemo-
dynamic response to exercise, and the absence of a specific 
heart structural exam is a limitation of our study. Despite 
this, it is important to note that all subjects enrolled in this 
study were normotensive and the mean resting SBP from 
the ACE DD genotype was only 124 mmHg (i.e. only 
slightly above that of the other groups).
There was also a trend for load-dependent differences 
in the BP response to resistance exercise for subjects with 
the different ACE gene polymorphism. Physical effort can 
stimulate the RAS,10,39–41 dependent on the load42 increas-
ing the ACE activity and circulating angiotensin II. 
Therefore, physical exertion and subsequent sympathetic 
activity stimulates renin release from the kidney, increas-
ing RAS activity.41 This may explain the differences 
among genotypes for HR and RPP only during exercise. 
Notwithstanding, another study43 found that men with the 
ACE DD genotype exhibit a greater pressor response to 
angiotensin I infusion than did men with the other ACE 
genotypes. Therefore, a greater sympathetic activity dur-
ing intense exercise could lead to a greater renin secretion 
and angiotensin I synthesis, inducing a greater pressor 
response to exercise in subjects with the ACE DD geno-
type. Of course, this is only speculation, as we did not con-
duct hormonal assessment, but nonetheless it is highly 
plausible.44
Based on our findings, we hypothesized that greater 
exercise loads may induce greater ACE activity and circu-
lating angiotensin II, but this idea should be tested in fur-
ther studies. Our results point to the need for future 
investigations about the relationship between the ACE I/D 
polymorphism and BP response to resistance exercise, and 
suggest this is a promising field for longitudinal investiga-
tions where the LV mass outcome may be observed after 
resistance exercise training with different loads (i.e. 50, 75 
or 100% of 10RM).
In summary, the ACE I/D polymorphism is associated 
with the hemodynamic response to resistance exercise, 
with healthy subjects having the ACE D allele being prone 
to higher hemodynamic (i.e. BP, HR and RPP) responses 
to resistance exercise. In addition, this phenotypic differ-
ence seems to induce a load-dependent trend in exercise 
responses. Based on our findings, we recommend that 
future studies should focus on two issues: 1) the long-term 
influence of a resistance training program with different 
workloads on the BP response and LV mass from healthy 
subjects with different ACE genotypes; 2) the influence of 
other polymorphisms of the RAS on the BP response and 
LV mass from healthy subjects submitted to a resistance 
training program (since we included only the ACE I/D 
polymorphism, because it is the most reported polymor-
phism of the RAS related to the hemodynamic and LV 
mass response to exercise).3,11,12,30–33
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